Vitestro raised $22million (€20 million) in funding to accelerate commercialization of its innovative blood drawing device. The funding was raised from Sonder Capital, NYBC Ventures, Invest-NL, and EIC. We advised Sonder Capital, NYBC Ventures.
Vitestro raised $22million (€20 million) in funding to accelerate commercialization of its innovative blood drawing device. The funding was raised from Sonder Capital, NYBC Ventures, Invest-NL, and EIC. We advised Sonder Capital, NYBC Ventures.